Preliminary studies with nebramycin factor 6.
D000606:Amino Sugars / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D004755:Enterobacteriaceae / Q000187:drug effects; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005839:Gentamicins / Q000008:administration & dosage / Q000097:blood / Q000652:urine; D006027:Glycosides / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D011549:Pseudomonas / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects
D000606:Amino Sugars; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D006027:Glycosides